Authors:
GULICK RM
MELLORS JW
HAVLIR D
ERON JJ
GONZALEZ C
MCMAHON D
JONAS L
MEIBOHM A
HOLDER D
SCHLEIF WA
CONDRA JH
EMINI EA
ISAACS R
CHODAKEWITZ JA
RICHMAN DD
Citation: Rm. Gulick et al., SIMULTANEOUS VS SEQUENTIAL INITIATION OF THERAPY WITH INDINAVIR, ZIDOVUDINE, AND LAMIVUDINE FOR HIV-1 INFECTION - 100-WEEK FOLLOW-UP, JAMA, the journal of the American Medical Association, 280(1), 1998, pp. 35-41
Authors:
SMITH AB
HIRSCHMANN R
PASTERNAK A
YAO WQ
SPRENGELER PA
HOLLOWAY MK
KUO LC
CHEN ZG
DARKE PL
SCHLEIF WA
Citation: Ab. Smith et al., AN ORALLY BIOAVAILABLE PYRROLINONE INHIBITOR OF HIV-1 PROTEASE - COMPUTATIONAL ANALYSIS AND X-RAY CRYSTAL-STRUCTURE OF THE ENZYME COMPLEX, Journal of medicinal chemistry, 40(16), 1997, pp. 2440-2444
Authors:
CONDRA JH
HOLDER DJ
SCHLEIF WA
BLAHY OM
DANOVICH RM
GABRYELSKI LJ
GRAHAM DJ
LAIRD D
QUINTERO JC
RHODES A
ROBBINS HL
ROTH E
SHIVAPRAKASH M
YANG T
CHODAKEWITZ JA
DEUTSCH PJ
LEAVITT RY
MASSARI FE
MELLORS JW
SQUIRES KE
STEIGBIGEL RT
TEPPLER H
EMINI EA
Citation: Jh. Condra et al., GENETIC CORRELATES OF IN-VIVO VIRAL RESISTANCE TO INDINAVIR, A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR, Journal of virology, 70(12), 1996, pp. 8270-8276
Authors:
CONLEY AJ
KESSLER JA
BOOTS LJ
MCKENNA PM
SCHLEIF WA
EMINI EA
MARK GE
KATINGER H
COBB EK
LUNCEFORD SM
ROUSE SR
MURTHY KK
Citation: Aj. Conley et al., THE CONSEQUENCE OF PASSIVE ADMINISTRATION OF AN ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZING MONOCLONAL-ANTIBODY BEFORE CHALLENGE OF CHIMPANZEES WITH A PRIMARY VIRUS ISOLATE, Journal of virology, 70(10), 1996, pp. 6751-6758
Authors:
GHOSH AK
KINCAID JF
WALTERS DE
CHEN Y
CHAUDHURI NC
THOMPSON WJ
CULBERSON C
FITZGERALD PMD
LEE HY
MCKEE SP
MUNSON PM
DUONG TT
DARKE PL
ZUGAY JA
SCHLEIF WA
AXEL MG
LIN J
HUFF JR
Citation: Ak. Ghosh et al., NONPEPTIDAL P-2 LIGANDS FOR HIV PROTEASE INHIBITORS - STRUCTURE-BASEDDESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION, Journal of medicinal chemistry, 39(17), 1996, pp. 3278-3290
Authors:
MELLORS JW
MCMAHON DK
CHODAKEWITZ JA
SCHLEIF WA
EMINI EA
CONDRA JH
Citation: Jw. Mellors et al., CORRELATION BETWEEN GENOTYPIC EVIDENCE OF HIV-1 RESISTANCE TO THE PROTEASE INHIBITOR MK-639 AND LOSS OF ANTIRETROVIRAL EFFECT IN TREATED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 71-71
Authors:
CONDRA JH
SCHLEIF WA
BLAHY OM
GABRYELSKI LJ
GRAHAM DJ
QUINTERO JC
RHODES A
ROBBINS HL
ROTH E
SHIVAPRAKASH M
TITUS D
YANG T
ZHANG J
CHODAKEWITZ JA
DEUTSCH PJ
EMINI EA
Citation: Jh. Condra et al., DYNAMICS OF ACQUIRED HIV-1 CLINICAL RESISTANCE TO THE PROTEASE INHIBITOR MK-639, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 72-72
Authors:
CONDRA JH
SCHLEIF WA
BLAHY OM
GABRYELSKI LJ
GRAHAM DJ
QUINTERO JC
RHODES A
ROBBINS HL
ROTH E
SHIVAPRAKASH M
TITUS D
YANG T
ZHANG J
DEUTSCH PJ
SQUIRES KE
EMINI EA
Citation: Jh. Condra et al., EVIDENCE FOR THE EXISTENCE OF LONG-LIVED GENETIC RESERVOIRS OF HIV-1 IN INFECTED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 82-82
Authors:
YOUNG SD
AMBLARD MC
BRITCHER SF
GREY VE
TRAN LO
LUMMA WC
HUFF JR
SCHLEIF WA
EMINI EE
OBRIEN JA
PETTIBONE DJ
Citation: Sd. Young et al., 2-HETEROCYCLIC INDOLE-3-SULFONES AS INHIBITORS OF HIV-1 REVERSE-TRANSCRIPTASE, Bioorganic & medicinal chemistry letters, 5(5), 1995, pp. 491-496
Authors:
YOUNG SD
BRITCHER SF
TRAN LO
PAYNE LS
LUMMA WC
LYLE TA
HUFF JR
ANDERSON PS
OLSEN DB
CARROLL SS
PETTIBONE DJ
OBRIEN JA
BALL RG
BALANI SK
LIN JH
CHEN IW
SCHLEIF WA
SARDANA VV
LONG WJ
BYRNES VW
EMINI EA
Citation: Sd. Young et al., L-743,726 (DMP-266) - A NOVEL, HIGHLY POTENT NONNUCLEOSIDE INHIBITOR OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE, Antimicrobial agents and chemotherapy, 39(12), 1995, pp. 2602-2605
Authors:
CONDRA JH
SCHLEIF WA
BLAHY OM
GABRYELSKI LJ
GRAHAM DJ
QUINTERO JC
RHODES A
ROBBINS HL
ROTH E
SHIVAPRAKASH M
TITUS D
YANG T
TEPPLER H
SQUIRES KE
DEUTSCH PJ
EMINI EA
Citation: Jh. Condra et al., IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS, Nature, 374(6522), 1995, pp. 569-571
Authors:
STASZEWSKI S
MASSARI FE
KOBER A
GOHLER R
DURR S
ANDERSON KW
SCHNEIDER CL
WATERBURY JA
BAKSHI KK
TAYLOR VI
HILDEBRAND CS
KREISL C
HOFFSTEDT B
SCHLEIF WA
VONBRIESEN H
RUBSAMENWAIGMANN H
CALANDRA GB
RYAN JL
STILLE W
EMINI EA
BYRNES VW
Citation: S. Staszewski et al., COMBINATION THERAPY WITH ZIDOVUDINE PREVENTS SELECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS EXPRESSING HIGH-LEVEL RESISTANCE TO L-697,661, A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR, The Journal of infectious diseases, 171(5), 1995, pp. 1159-1165
Authors:
SMITH AB
HIRSCHMANN R
PASTERNAK A
GUZMAN MC
YOKOYAMA A
SPRENGELER PA
DARKE PL
EMINI EA
SCHLEIF WA
Citation: Ab. Smith et al., PYRROLINONE-BASED HIV PROTEASE INHIBITORS - DESIGN, SYNTHESIS, AND ANTIVIRAL ACTIVITY - EVIDENCE FOR IMPROVED TRANSPORT, Journal of the American Chemical Society, 117(45), 1995, pp. 11113-11123
Authors:
GORNY M
WILLIAMS C
ZOLLAPAZNER S
OSSORIO M
BANSAL G
KOENIG S
CONLEY AJ
KESSLER JA
BOOTS LJ
LINEBERGER D
SCHLEIF WA
EMINI EA
Citation: M. Gorny et al., A BROADLY REACTIVE HUMAN ANTI-V3 MONOCLONAL-ANTIBODY EFFECTIVELY NEUTRALIZES PRIMARY HIV-1 ISOLATES, AIDS research and human retroviruses, 10, 1994, pp. 190000034-190000034
Authors:
SCHLEIF WA
MURTHY KK
SARDANA VV
SCHNEIDER CL
BYRNES VW
COBB KE
ROTH E
WOLFGANG JA
HOFFMAN JM
SMITH AM
GELOTTE KM
EMINI EA
Citation: Wa. Schleif et al., ATTEMPTED PROPHYLAXIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN CHIMPANZEES WITH A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR, AIDS research and human retroviruses, 10(1), 1994, pp. 107-110
Authors:
HUFF JR
VACCA JP
DORSEY BD
THOMPSON WJ
GHOSH AK
HUNGATE RW
LEE HY
DARKE PL
EMINI EA
SCHLEIF WA
LIN JH
CHEN IW
HOLLOWAY MK
ANDERSON PS
Citation: Jr. Huff et al., THE DESIGN AND SYNTHESIS OF ORALLY BIOAVAILABLE HIV-1 PROTEASE INHIBITORS, Journal of cellular biochemistry, 1994, pp. 130-130
Authors:
CONDRA JH
BLAHY OM
BUSH BL
CULBERSON C
GOTLIB L
GRAHAM DJ
GRAHAM PL
HOLLOWAY MK
LAFEMINA RL
QUINTERO JC
RHODES A
ROTH E
SARDANA VV
SCHNEIDER CL
SCHLABACH AJ
SCHLEIF WA
TITUS DL
WOLANSKI BS
WOLFGANG JA
EMINI EA
Citation: Jh. Condra et al., MUTATIONS IN HIV-1 PROTEASE RESIDUES AFFECTING SUSCEPTIBILITY TO L-735,524, Journal of cellular biochemistry, 1994, pp. 166-166
Authors:
EMINI EA
BYRNES VW
CONDRA JH
SCHLEIF WA
SARDANA VV
Citation: Ea. Emini et al., THE GENETIC AND FUNCTIONAL BASIS OF HIV-1 RESISTANCE TO NONNUCLEOSIDEREVERSE-TRANSCRIPTASE INHIBITORS, Archives of virology, 1994, pp. 11-17
Authors:
BYRNES VW
EMINI EA
SCHLEIF WA
CONDRA JH
SCHNEIDER CL
LONG WJ
WOLFGANG JA
GRAHAM DJ
GOTLIB L
SCHLABACH AJ
WOLANSKI BS
BLAHY OM
QUINTERO JC
RHODES A
ROTH E
TITUS DL
SARDANA VV
Citation: Vw. Byrnes et al., SUSCEPTIBILITIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENZYME AND VIRAL VARIANTS EXPRESSING MULTIPLE RESISTANCE-ENGENDERING AMINO-ACID SUBSTITUTIONS TO REVERSE-TRANSCRIPTASE INHIBITORS, Antimicrobial agents and chemotherapy, 38(6), 1994, pp. 1404-1407
Authors:
VACCA JP
DORSEY BD
SCHLEIF WA
LEVIN RB
MCDANIEL SL
DARKE PL
ZUGAY J
QUINTERO JC
BLAHY OM
ROTH E
SARDANA VV
SCHLABACH AJ
GRAHAM PI
CONDRA JH
GOTLIB L
HOLLOWAY MK
LIN J
CHEN IW
VASTAG K
OSTOVIC D
ANDERSON PS
EMINI EA
HUFF JR
Citation: Jp. Vacca et al., L-735,524 - AN ORALLY BIOAVAILABLE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR, Proceedings of the National Academy of Sciences of the United Statesof America, 91(9), 1994, pp. 4096-4100
Authors:
GHOSH AK
LEE HY
THOMPSON WJ
CULBERSON C
HOLLOWAY MK
MCKEE SP
MUNSON PM
DUONG TT
SMITH AM
DARKE PL
ZUGAY JA
EMINI EA
SCHLEIF WA
HUFF JR
ANDERSON PS
Citation: Ak. Ghosh et al., THE DEVELOPMENT OF CYCLIC SULFOLANES AS NOVEL AND HIGH-AFFINITY P(2) LIGANDS FOR HIV-1 PROTEASE INHIBITORS, Journal of medicinal chemistry, 37(8), 1994, pp. 1177-1188
Authors:
DORSEY BD
LEVIN RB
MCDANIEL SL
VACCA JP
GUARE JP
DARKE PL
ZUGAY JA
EMINI EA
SCHLEIF WA
QUINTERO JC
LIN JH
CHEN IW
HOLLOWAY MK
FITZGERALD PMD
AXEL MG
OSTOVIC D
ANDERSON PS
HUFF JR
Citation: Bd. Dorsey et al., L-735,524 - THE DESIGN OF A POTENT AND ORALLY BIOAVAILABLE HIV PROTEASE INHIBITOR, Journal of medicinal chemistry, 37(21), 1994, pp. 3443-3451